Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castration Levels of Testosterone × apalutamide × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 33 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Non-Muscle Invasive Bladder Urothelial Carcinoma 1 Neoplasm Metastasis 1 Metastatic Hormone-sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castrate-sensitive Prostate Cancer 1 Castration Levels of Testosterone 1 Adenocarcinoma 1

Interventions

apalutamide 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03503344 2026-01-21

PILLAR

University of California, San Francisco

Phase 2 Completed

26 enrolled 11 charts

Castration Levels of Testosterone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡